Effect of coadministration of propranolol and etodolac (VT-122) plus sorafenib for patients with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | de la Torre, A. N.; Castaneda, I.; Hezel, A. F.; Bascomb, N. F.; Bhattacharyya, G. S.; Abou-Alfa, G. K. |
| Abstract Title: | Effect of coadministration of propranolol and etodolac (VT-122) plus sorafenib for patients with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 2015 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2015 Jan 15-17 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-01-20 |
| Language: | English |
| ACCESSION: | WOS:000356883800388 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.3_suppl.390 |
| Notes: | Meeting Abstract: 390 -- Source: Wos |
